Katia Alloun

Katia Alloun is a highly experienced pharmacovigilance specialist currently serving as the Safety Contact Person for Spain at LEO Pharma since June 2023. Previously, Katia held the position of Manager, Medical at the World Anti-Doping Agency from January 2019 to June 2023, where responsibilities included monitoring Therapeutic Use Exemptions and managing medical project initiatives. Prior to this, Katia gained extensive experience in drug safety roles at GSK, Pfizer, Ranbaxy, Roche, Sandoz, and Ferring Pharmaceuticals, contributing to adverse event reporting, safety audits, and regulatory compliance. Katia holds a Doctor of Pharmacy degree from Université Paris Cité and a Master of Science in Toxicology, Risk Assessment, and Vigilance. Additionally, an exchange program in Pharmacy was completed at Universitat de Barcelona.